These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17702832)

  • 1. Levosimendan in septic shock: a case series.
    Powell BP; De Keulenaer BL
    Br J Anaesth; 2007 Sep; 99(3):447-8. PubMed ID: 17702832
    [No Abstract]   [Full Text] [Related]  

  • 2. BET 1: levosimendan in septic shock.
    Coates J; Mathieu S
    Emerg Med J; 2014 Jun; 31(6):508-10. PubMed ID: 24839073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful reversal of resistent hypodynamic septic shock with levosimendan.
    Matejovic M; Krouzecky A; Radej J; Novak I
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):127-8. PubMed ID: 15676005
    [No Abstract]   [Full Text] [Related]  

  • 4. Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking.
    De Backer D; Taccone FS; Radermacher P
    Intensive Care Med; 2007 Mar; 33(3):403-5. PubMed ID: 17262189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levosimendan for septic shock with takotsubo cardiomyopathy].
    Schlürmann CN; Reinöhl J; Kalbhenn J
    Anaesthesist; 2016 Jan; 65(1):46-49. PubMed ID: 26620046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan in septic cardiac failure.
    Noto A; Giacomini M; Palandi A; Stabile L; Reali-Forster C; Iapichino G
    Intensive Care Med; 2005 Jan; 31(1):164-5. PubMed ID: 15580334
    [No Abstract]   [Full Text] [Related]  

  • 7. Levosimendan in early sepsis: when good ideas give poor results.
    De Backer D; Bracht H
    Anesth Analg; 2009 Nov; 109(5):1367-9. PubMed ID: 19843771
    [No Abstract]   [Full Text] [Related]  

  • 8. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
    Bhattacharjee S; Soni KD; Maitra S; Baidya DK
    J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
    Zangrillo A; Putzu A; Monaco F; Oriani A; Frau G; De Luca M; Di Tomasso N; Bignami E; Lomivorotov V; Likhvantsev V; Landoni G
    J Crit Care; 2015 Oct; 30(5):908-13. PubMed ID: 26093802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan for treatment of septic shock: homeotherapy or inadequate therapy?
    Yang JJ; Ji MH; Sun J; Peng YG
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1147; author reply 1147-8. PubMed ID: 22092214
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A; De Castro S; Teboul JL; Singer M; Rocco M; Conti G; De Luca L; Di Angelantonio E; Orecchioni A; Pandian NG; Pietropaoli P
    Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paediatric use of levosimendan in septic shock].
    Monteverde E; Neira P; Farías J
    An Pediatr (Barc); 2008 May; 68(5):529-30. PubMed ID: 18448005
    [No Abstract]   [Full Text] [Related]  

  • 14. Levosimendan: a new option in acute septic cardiac failure?
    Powell BP; De Keulenaer B
    Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial depression associated with pneumococcal septic shock reversed by levosimendan.
    Ramaswamykanive H; Bihari D; Solano TR
    Anaesth Intensive Care; 2007 Jun; 35(3):409-13. PubMed ID: 17591138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined arginine vasopressin and levosimendan: a promising therapy for septic shock.
    Yang JJ; Wang X; Ji MH; Peng YG
    Crit Care Med; 2011 Apr; 39(4):921-2; author reply 922. PubMed ID: 21613859
    [No Abstract]   [Full Text] [Related]  

  • 17. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 18. Levosimendan in cardiogenic shock: better than enoximone!
    Buerke M; Prondzinsky R
    Crit Care Med; 2008 Aug; 36(8):2450-1. PubMed ID: 18664796
    [No Abstract]   [Full Text] [Related]  

  • 19. Levosimendan or enoximone in refractory cardiogenic shock?
    Berthelsen PG
    Crit Care Med; 2009 Mar; 37(3):1182. PubMed ID: 19237971
    [No Abstract]   [Full Text] [Related]  

  • 20. [Levosimendan-no effect on multiorgan failure in septic shock].
    Janssens U
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):254-257. PubMed ID: 28108776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.